Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of HWH486 in adults with chronic spontaneous urticaria
CTR20233777Phase 2Active
- Sponsor
- Hubei Institute of Biopharmaceutical Industry
- Start
- Mar 2024
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of HWH486 in chronic idiopathic urticaria (CIU), sponsored by Hubei Institute of Biopharmaceutical Industry. Started Mar 2024; status: active.
02
Drugs
HWH486
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on CTR20233777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233777.